26 July 2021 - The TGA's International Engagement Strategy 2021-2025 describes how working with our international regulatory counterparts will benefit Australians ...
20 July 2021 - To help make the medicines application process more efficient, the TGA no longer allocates proprietary ingredient ...
20 July 2021 - Medicines Australia welcomes the clinical trial ‘one-stop-shop’ consultation, recently announced by the Australian Commission on Safety ...
15 July 2021 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 14 ...
5 July 2021 - Joint Statement from the International Coalition of Medicines Regulatory Authorities and World Health Organization. ...
5 July 2021 - This project has been established to enhance the adverse event reporting processes. ...
24 June 2021 - Today, the Therapeutic Goods Administration granted provisional determination to Moderna Australia in relation to the COVID-19 ...
23 June 2021 - The TGA is required to recover its costs for all activities that fall within the scope of ...
22 June 2021 - The TGA is a member of the Access consortium along with Health Canada, Health Sciences Authority of ...
17 June 2021 - Twelve additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
10 June 2021 - Seven additional cases of blood clots with low blood platelets have been assessed as thrombosis with ...
7 June 2021 - Regulatory changes introducing a new framework for the regulation of personalised medical devices commenced on 25 ...
23 May 2021 - The Australian Technical Advisory Group on Immunisation and the Thrombosis and Haemostasis Society of Australia and New ...
17 May 2021 - The nation’s medicines regulator is looking at a plan to give Australians more freedom to access ...
6 May 2021 - Medicines Australia continues to express our sympathies to all those affected by the pandemic. The importance ...